HCPCS Codes Similar to J3357

HCPCS Codes Similar to “J3357” Code.
Ustekinumab, for subcutaneous injection, 1 mg

Q5137 Injection, ustekinumab-auub (wezlana), biosimilar, subcutaneous, 1 mg Code added date: 20240701 Code effective date: 20240701 TXT \| PDF \| XML \| JSON	Q9996 Injection, ustekinumab-ttwe (pyzchiva), subcutaneous, 1 mg Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON
C9487 Ustekinumab, for intravenous injection, 1 mg Code added date: 20170401 Code effective date: 20170701 TXT \| PDF \| XML \| JSON	J3358 Ustekinumab, for intravenous injection, 1 mg Code added date: 20180101 Code effective date: 20180101 TXT \| PDF \| XML \| JSON
Q5098 Injection, ustekinumab-srlf (imuldosa), biosimilar, 1 mg Code added date: 20250701 Code effective date: 20250701 TXT \| PDF \| XML \| JSON	Q5099 Injection, ustekinumab-stba (steqeyma), biosimilar, 1 mg Code added date: 20250701 Code effective date: 20250701 TXT \| PDF \| XML \| JSON
Q5100 Injection, ustekinumab-kfce (yesintek), biosimilar, 1 mg Code added date: 20250701 Code effective date: 20250701 TXT \| PDF \| XML \| JSON	Q5138 Injection, ustekinumab-auub (wezlana), biosimilar, intravenous, 1 mg Code added date: 20240701 Code effective date: 20240701 TXT \| PDF \| XML \| JSON
Q9989 Ustekinumab, for intravenous injection, 1 mg Code added date: 20170701 Code effective date: 20180101 TXT \| PDF \| XML \| JSON	Q9997 Injection, ustekinumab-ttwe (pyzchiva), intravenous, 1 mg Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON
Q9998 Injection, ustekinumab-aekn (selarsdi), biosimilar, 1 mg Code added date: 20250101 Code effective date: 20250701 TXT \| PDF \| XML \| JSON	Q9999 Injection, ustekinumab-aauz (otulfi), biosimilar, 1 mg Code added date: 20250401 Code effective date: 20250401 TXT \| PDF \| XML \| JSON
J2354 Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg Code added date: 20040101 Code effective date: 20040101 TXT \| PDF \| XML \| JSON	M0240 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, subsequent repeat doses Code added date: 20210730 Code effective date: 20241213 TXT \| PDF \| XML \| JSON